AKT1 and hepatocellular carcinoma: Clinical evidence has strongly supported the negative regulatory role of CBS in proliferative diseases (Kim et al., 2009), which induces autophagy and apoptosis via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma (HCC) cells (Zhu et al., 2018).